Showing 1 - 3 results of 3 for search 'Mirjam HM Heemskerk', query time: 0.03s Refine Results
  1. 1
    PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy

    PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy by Sietse J Luk, Dirk M van der Steen, Renate S Hagedoorn, Ekaterina S Jordanova, Marco W Schilham, Judith VMG Bovée, Arjen HG Cleven, JH Frederik Falkenburg, Karoly Szuhai, Mirjam HM Heemskerk

    Published 2018-12-01
    Get full text
    Article
  2. 2
    SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells

    SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells by Cilia R Pothast, Romy C Dijkland, Melissa Thaler, Renate S Hagedoorn, Michel GD Kester, Anne K Wouters, Pieter S Hiemstra, Martijn J van Hemert, Stephanie Gras, JH Frederik Falkenburg, Mirjam HM Heemskerk

    Published 2022-11-01
    Get full text
    Article
  3. 3
    Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial

    Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial by Felix S Lichtenegger, Frauke M Schnorfeil, Maurine Rothe, Katrin Deiser, Torben Altmann, Veit L Bücklein, Thomas Köhnke, Christian Augsberger, Nikola P Konstandin, Karsten Spiekermann, Andreas Moosmann, Stephan Boehm, Melanie Boxberg, Mirjam HM Heemskerk, Dennis Goerlich, Georg Wittmann, Beate Wagner, Wolfgang Hiddemann, Dolores J Schendel, Gunnar Kvalheim, Iris Bigalke, Marion Subklewe

    Published 2020-01-01
    Get full text
    Article

Search Tools: